Incremental innovation in healthcare in Spain during the COVID-19 pandemic
e202303018
Keywords:
Incremental innovation, Utility models, COVID-19Abstract
BACKGROUND // It is important to understand the impact of the COVID-19 pandemic on incremental innovation and its protection through industrial property rights, in order to acquiring valuable insights to develop effective public policies and corporate strategies. The objective was to analyze incremental innovations in response to the pandemic that have been protected by industrial property rights, and to examine whether the COVID-19 pandemic had a positive or negative effect on incremental innovation, promoting or inhibiting it.
METHODS // Utility models in the health patent class have been used as indicators (01.01.20 to 31.12.21), since the information they provide and their characteristics (requirements of applications and publication) allowed us to obtain preliminary conclusions in the short term. Their frequency of application during the pandemic months was analyzed and compared with an equivalent period immediately before (01.01.18 to 31.12.19).
RESULTS // The analysis showed that there had been greater activity in healthcare innovation by all agents (individuals, companies and the public sector). In the pandemic period of 2020-2021, 754 utility models were requested, representing a nearly 40% increase compared to the equivalent period of 2018-2019, of which 284 were identified as pandemic-related innovations, with 59.7% of rights holders being individuals, 36.4% being companies, and only 3.9% being public entities.
CONCLUSIONS // In general, incremental innovations require less investment and shorter technology maturation times, which had made it possible to respond, in some cases successfully, to situations of initial shortages of many medical devices, such as ventilators and protective equipment.
Downloads
References
Archibugi D, Filippetti A, Frenz M. The impact of the economic crisis on innovation: Evidence from Europe. Technol Forecast Soc Change. 2013;80(7):1247-1260.
Hingley P, Park WG. Do business cycles affect patenting? Evidence from European Patent Office filings. Technol Forecast Soc Change. 2017;116:76-86.
Carmeli A, Schaubroeck J. Organisational crisis-preparedness: The importance of learning from failures. Long Range Plann. 2008;41(2):177-196.
Cefis E, Marsili O. Good times, bad times: innovation and survival over the business cycle. Ind Corp Change. 2019;28(3):565-587.
Hoegl M, Gibbert M, Mazursky D. Financial constraints in innovation projects: When is less more? Res Policy. 2008;37(8):1382-1391.
Cruz-Castro L, Holl A, Rama R, Sanz-Menéndez L. Economic crisis and company R&D in Spain: do regional and policy factors matter? Ind Innov. 2018;25(8):729-751.
Argüello A, Ortega-Rodriguez A, Álvarez P. Methodological proposal to explore and design future health innovation policies and opportunities for Responsible Research and Innovation (RRI). medRxiv. 2021. p. 2021.05.10.21256984.
Campbell RS. Patent trends as a technological forecasting tool. World Pat Inf. 1983;5(3):137-143.
Manual O. The measurement of scientific, technological and innovation activities. Paris, France: OECD Publishing; 2018.
OECD. OECD pandemia [Internet]. Disponible en: https://www.oecd.org/sti/science-technology-innovation-outlook/crisis-and-opportunity/responsestothecrisishavedrawnupontheinnovativepotentialofbusinesses.htm
Djellal F, Gallouj F. Innovation in hospitals: a survey of the literature. Eur J Health Econ. 1 de septiembre de 2007;8(3):181-193.
Rey-Rocha J, López-Navarro I. The fourth mission of hospitals and the role of researchers as innovation drivers in the public healthcare sector. Rev Esp Doc Científica. agosto de 2013;37.
Pablo F, Arenas J. Introducción al Plan Nacional de Investigación, Desarrollo e Innovación 2008-2011: la acción estratégica en salud. Med Clin (Barc). 2008;130:223-227.
OEPM infografías [Internet]. Disponible en: https://www.oepm.es/es/sobre_oepm/actividades_estadisticas/EstadisticasPropiedadIndustrial/LaOEPMenCifras_Infografias/
Etzkowitz H. Innovation in Innovation: The Triple Helix of University-Industry-Government Relations. Soc Sci Inf. 2003;42(3):293-337.
Published
How to Cite
License
Copyright (c) 2023 Arturo Argüello, Roke Iñaki Oruezabal, Marta Reyes, Pablo Álvarez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
